Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05895279 · ClinicalTrials.gov registry record · NA
Assessment of Research Digest Impact for Minority with Prostate Cancer, MiCAP Phase III Study
A NA study, sponsored by Mayo Clinic.
- Completed
- Registry status
- NA
- Development phase
- 220
- Enrollment target
NCT05895279 is a NA study that has completed, run by Mayo Clinic. The registered enrollment target is 220 participants.
The verdict
NCT05895279, a NA study, has completed, sponsored by Mayo Clinic.
- COMPLETED
- Registry status
- NA
- Development phase
- 220 participants
- Enrollment target
Study Summary
This phase III trial determines how well the Minority Prostate Cancer (MiCaP) Research Digest works in providing information to black men about the latest prostate cancer research. MiCaP Research Digest may be an effective method to help people learn about prostate cancer.This goal of this trial is to create educational programming that helps Black men make informed decisions about their prostate healthcare since Black men are diagnosed with prostate cancer more than any other race or ethnicity.
Interventions
- OTHER Survey Administration
- OTHER Media Intervention
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 220 participants |
| Start Date | 2021-08-02 |
| Est. Completion | 2021-10-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05895279
The ClinicalTrials.gov registry entry for NCT05895279 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 220 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Mayo Clinic, which has 2,844 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Survey Administration is the first listed.
NCT05895279 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05895279 about?
NCT05895279 is a clinical study titled "Assessment of Research Digest Impact for Minority with Prostate Cancer, MiCAP Phase III Study". This phase III trial determines how well the Minority Prostate Cancer (MiCaP) Research Digest works in providing information to black men about the latest prostate cancer research. MiCaP Research Digest may be an effective method to help people learn about prostate cancer.This goal of this trial is ...
What is the current status of trial NCT05895279?
This trial is currently completed. It is a NA study. The enrollment target is 220 participants. The study started on 2021-08-02. Estimated completion is 2021-10-01.
What interventions are being tested in trial NCT05895279?
The interventions under investigation include: Survey Administration (OTHER), Media Intervention (OTHER).
Who is sponsoring clinical trial NCT05895279?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.